logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Myung‐Ju Ahn

Hanyang University Medical Center

109H-index
1.3KPaper Count
7.2WCitation Count
Published Papers 261
Publication Date
logo
Leptomeningeal Metastasis in Non-Small-Cell Lung Cancer with Actionable Genomic Alterations: Pathogenesis, Diagnosis, and Emerging Therapeutic Strategies
errCancers
IF4.4
err2026-07-28
err0
errOAAI
errSung-Won Lim; Bo Mi Ku; Myung-Ju Ahn
errShare
errSave
Author Correction: SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
errNature Medicine
IF50
err2026-06-29
err0
errOAAI
errLauren Averett Byers; Byoung Chul Cho; Alissa J. Cooper; Anne C. Chiang; Ji-Youn Han; Muhammad Furqan; Afshin Dowlati; Daniel Morgensztern; Kyriakos P. Papadopoulos; Noura J. Choudhury; María Vieito; Jair Bar; Joo-Hang Kim; Wallace Akerley; Tae Min Kim; Young-Chul Kim; Luis Paz-Ares; Myung-Ju Ahn; Hiroshi Yokouchi; Darius Meiman; Wijith Munasinghe; Oluwadamilola Ogunyankin; Nadine Jahchan; Song Wang; Cristiano Ferlini; Randy R. Robinson; Frederick J. Kohlhapp; Tammy Palenski; Guillermo Rivell; Pooja Hingorani; Sreenivasa Chandana
errShare
errSave
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
errNature Medicine
IF50
err2026-06-01
err0
errOAAI
errLauren Averett Byers; Byoung Chul Cho; Alissa J. Cooper; Anne C. Chiang; Ji-Youn Han; Muhammad Furqan; Afshin Dowlati; Daniel Morgensztern; Kyriakos P. Papadopoulos; Noura J. Choudhury; María Vieito; Jair Bar; Joo-Hang Kim; Wallace Akerley; Tae Min Kim; Young-Chul Kim; Luis Paz-Ares; Myung-Ju Ahn; Hiroshi Yokouchi; Darius Meiman; Wijith Munasinghe; Oluwadamilola Ogunyankin; Nadine Jahchan; Song Wang; Cristiano Ferlini; Randy R. Robinson; Frederick J. Kohlhapp; Tammy Palenski; Guillermo Rivell; Pooja Hingorani; Sreenivasa Chandana
errShare
errSave
A plain language review of results from the LAURA study: osimertinib after chemoradiotherapy for patients with EGFR-mutated non-small cell lung cancer that cannot be removed by surgery
errFuture Oncology
IF2.6
err2026-04-27
err0
errOAAI
errShun Lu; Terufumi Kato; Xiaorong Dong; Myung-Ju Ahn; Le-Van Quang; Nopadol Soparattanapaisarn; Takako Inoue; Chih-Liang Wang; Meijuan Huang; James Chih-Hsin Yang; Manuel Cobo; Mustafa Özgüroğlu; Ignacio Casarini; Virote Sriuranpong; Eduardo Cronemberger; Toshiaki Takahashi; Yotsawaj Runglodvatana; Ming Chen; Xiangning Huang; Ellie Grainger; Dana Ghiorghiu; Toon van der Gronde; Suresh S Ramalingam
errShare
errSave
Evaluating zongertinib in the treatment of patients with HER2-mutant non-small cell lung cancer
errFuture Oncology
IF2.6
err2026-04-22
err0
PREAI
errJinyong Kim; Myung-Ju Ahn
errShare
errSave
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study
errOral Oncology
IF3.9
err2025-11-22
err0
errOAAI
errKevin J. Harrington; Ari J. Rosenberg; Muh-Hwa Yang; Jessica L. Geiger; Marc Oliva; Myung-Ju Ahn; Sun Min Lim; William Ince; Aarti Bhatia; Siddharth Sheth; Bhumsuk Keam; Robert Metcalf; Joshua C. Curtin; Kiichiro Toyoizumi; Mark Wade; Emrullah Yilmaz; Priya Kim; Remy B. Verheijen; Sujay Shah; Mahadi Baig
errShare
errSave
Datopotamab deruxtecan versus docetaxel for non-small cell lung cancer: a plain language summary of the TROPION-Lung01 study
errFUTURE ONCOLOGY
IF2.6
err2025-11-01
err1
PREAI
errSands, Jacob; Ahn, Myung-Ju
errShare
errSave
Combination of chemotherapy and immune checkpoint inhibitors in non-small cell lung cancer with actionable gene alterations other than EGFR, ALK, and ROS1 mutations: a retrospective observational study
errBMC Cancer
IF3.4
err2025-10-23
err0
errOAAI
errJi Eun Shin; Sehhoon Park; Hyun Ae Jung; Jong-Mu Sun; Se-Hoon Lee; Jin Seok Ahn; Myung-Ju Ahn
errShare
errSave
Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 Trial
errJournal of Thoracic Oncology
IF20.8
err2025-10-19
err0
errOAAI
errYeong Hak Bang; Jae Myoung Noh; Boram Lee; Yoon-La Choi; Kyungmi Yang; Hongryull Pyo; Hyunsu Kim; Jinyong Kim; Hyun Ae Jung; Jong-Mu Sun; Se-Hoon Lee; Jin Seok Ahn; Myung-Ju Ahn; Yeong Jeong Jeon; Junghee Lee; Jong Ho Cho; Hong Kwan Kim; Yong Soo Choi; Seong Yong Park; Sehhoon Park
errShare
errSave
Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial)
errESMO Open
IF8.3
err2025-09-17
err0
PREAI
errS. Hwang; M.H. Hong; S.H. Shin; T. Yun; K.-W. Lee; J.H. Kim; M.J. Ahn; B. Keam; H.W. Lee; M.K. Kim; H.J. Yun; Y. Kim; H.J. Kim; S.H. Cho; H.J. An; S.Y. Oh; S.-G. Park; Y.W. Koh; H.K. Ahn; J.H. Kwon; Y.-G. Lee; K.-U. Park; I.G. Hwang; S.-B. Kim; S. Kim; H.R. Kim
errShare
errSave
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study
errThe Lancet Oncology
IF0
err2025-09-08
err0
PREAI
errKelly G Paulson; Sally C M Lau; Myung-Ju Ahn; Mor Moskovitz; Michael Pogorzelski; Simon Häfliger; Amanda Parkes; Yuyang Zhang; Ali Hamidi; Corbin G Thompson; Martin Wermke
errShare
errSave
Central nervous system outcomes of lazertinib treatment in EGFR-mutated advanced NSCLC: Pooled analysis from LASER201 and LASER301
errClinical Lung Cancer
IF3.3
err2025-09-01
err0
PREAI
errJames CH Yang; Myung-Ju Ahn; Joo-Hang Kim; Yun-Gyoo Lee; Ji-Youn Han; Ki Hyeong Lee; Anastasia Zimina; Dong-Wan Kim; Kyung-Hee Lee; Sung Sook Lee; Chun Sen Lim; Yueh Ni Lim; Young Joo Min; Sergey Orlov; Youngjoo Lee; YuKyung Kim; Mi-Jung Kwon; Hana Lee; Hyeonchae Cho; Byoung Chul Cho
errShare
errSave
Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
errAnnals of Oncology
IF65.4
err2025-08-28
err0
PREAI
errA. Zer; M.-J. Ahn; F. Barlesi; L. Bubendorf; D. De Ruysscher; P. Garrido; O. Gautschi; L.E. Hendriks; P.A. Jänne; K.M. Kerr; C. Mascaux; T. Mitsudomi; S. Peters; C. Rolfo; A. Sacher; S. Senan; P. Ugalde; N.B. Leighl
errShare
errSave
Novel cancer-associated secretory cells and IL-1β+ macrophages as key players in early lung adenocarcinoma progression in female never-smokers
errClinical and Translational Medicine
IF6.8
err2025-08-18
err0
errOAAI
errJunsu Choe; Jinyeong Lim; Noeul Kang; Eun Seop Seo; Mina Hwang; Kyung Yeon Han; Se-Hoon Lee; Myung-Ju Ahn; Yoon-La Choi; Hong Kwan Kim; Woong-Yang Park; Sang-Won Um
errShare
errSave
A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC
errJournal of Thoracic Oncology
IF20.8
err2025-06-12
err0
errOAAI
errMyung-Ju Ahn; Aaron Lisberg; Yasushi Goto; Jacob Sands; Min Hee Hong; Luis Paz-Ares; Elvire Pons-Tostivint; Maurice Pérol; Enriqueta Felip; Shunichi Sugawara; Hidetoshi Hayashi; Byoung Chul Cho; George Blumenschein; Elaine Shum; Jong-Seok Lee; Rebecca S. Heist; Robin Cornelissen; Wen-Cheng Chang; Dariusz Kowalski; Hong Zebger-Gong; Michael Chargualaf; Wen Gu; Lan Lan; Paul Howarth; Richard Joseph; Isamu Okamoto
errShare
errSave
Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trial
erreClinicalMedicine
IF10
err2025-06-04
err0
errOAAI
errJhingook Kim; Yeong Hak Bang; Sehhoon Park; Hyun-Ae Jung; Jong-Mu Sun; Jin Seok Ahn; Myung-Ju Ahn; Yeong Jeong Jeon; Junghee Lee; Jong Ho Cho; Hong Kwan Kim; Yong Soo Choi; Jae Ill Zo; Young Mog Shim; Jung Hee Kang; Jinseon Lee; Yoon-La Choi; Joungho Han; Soohyun Hwang; Ho Yun Lee; Se-Hoon Lee
errShare
errSave
Updates on the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer
errCANCER
IF5.1
err2025-04-02
err0
PREAI
errKim, Jinyong; Park, Sehhoon; Ku, Bo Mi; Ahn, Myung-Ju
errShare
errSave
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17) (vol 9, 103668, 2024)
errESMO OPEN
IF8.3
err2025-04-01
err0
PREAI
errKang, E. J.; Yang, Y.; Lee, S.; Kim, Y. J.; Lim, S. M.; Ahn, M. -j.; Choi, Y. J.; Lee, Y.; Kim, T. M.; Kim, I.; Ahn, H. K.; Jeung, H. -c.; Lee, S. I.; Oh, S. Y.; Bae, W. K.; Ryu, H.; Park, K. H.; Lee, K. H.
errShare
errSave
Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial
errADVANCES IN THERAPY
IF4
err2025-03-01
err0
errOAAI
errHummel, Horst-Dieter; Ahn, Myung-Ju; Blackhall, Fiona; Reck, Martin; Akamatsu, Hiroaki; Ramalingam, Suresh S.; Borghaei, Hossein; Johnson, Melissa; Dirnberger, Franziska; Cocks, Kim; Huang, Shuang; Mukherjee, Sujoy; Paz-Ares, Luis
errShare
errSave
Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer
errSCIENTIFIC REPORTS
IF3.9
err2025-02-07
err0
errOAAI
errShin, Ji Eun; Jung, Hyun Ae; Park, Sehhoon; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Ahn, Myung-Ju; Shim, Byoung Yong
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
Michael Weller
H-index: 175 · Papers: 2.8K
M
Manel Esteller
H-index: 165 · Papers: 1.6K
P
Pasi A. Jänne
H-index: 163 · Papers: 2.3K
P
Peter J. Park
H-index: 145 · Papers: 810
J
James Chih‐Hsin Yang
H-index: 141 · Papers: 1.2K
View more